GlaxoSmithKline plc’s (GSK) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their neutral rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report report published on Monday morning. They currently have a GBX 1,750 ($22.48) price objective on the stock.

Other analysts have also issued research reports about the company. Liberum Capital reissued a buy rating and issued a GBX 1,900 ($24.41) target price on shares of GlaxoSmithKline plc in a research report on Tuesday, January 31st. Morgan Stanley reissued an equal weight rating and issued a GBX 1,700 ($21.84) target price on shares of GlaxoSmithKline plc in a research report on Monday, February 6th. Deutsche Bank AG reissued a hold rating and issued a GBX 1,720 ($22.09) target price (down previously from GBX 1,800 ($23.12)) on shares of GlaxoSmithKline plc in a research report on Thursday, February 9th. Goldman Sachs Group Inc set a GBX 1,850 ($23.76) target price on GlaxoSmithKline plc and gave the company a buy rating in a research report on Thursday, February 9th. Finally, HSBC Holdings plc reissued a buy rating and issued a GBX 1,970 ($25.31) target price on shares of GlaxoSmithKline plc in a research report on Thursday, February 9th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of GBX 1,751.77 ($22.50).

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

Shares of GlaxoSmithKline plc (LON:GSK) opened at 1702.00 on Monday. The company’s market capitalization is GBX 83.16 billion. GlaxoSmithKline plc has a 12-month low of GBX 1,363.00 and a 12-month high of GBX 1,745.56. The firm has a 50-day moving average price of GBX 1,619.26 and a 200 day moving average price of GBX 1,591.69.

COPYRIGHT VIOLATION WARNING: “GlaxoSmithKline plc’s (GSK) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.” was published by Mideast Time and is the sole property of of Mideast Time. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.mideasttime.com/glaxosmithkline-plcs-gsk-neutral-rating-reaffirmed-at-jpmorgan-chase-co-2/1744704.html.

The business also recently announced a dividend, which will be paid on Thursday, July 13th. Shareholders of record on Thursday, May 11th will be issued a GBX 19 ($0.24) dividend. The ex-dividend date is Thursday, May 11th. This represents a yield of 1.21%.

In related news, insider Vivienne Cox bought 335 shares of the company’s stock in a transaction on Wednesday, April 26th. The stock was bought at an average cost of GBX 1,583 ($20.33) per share, with a total value of £5,303.05 ($6,811.88). Also, insider Emma Walmsley bought 83 shares of the company’s stock in a transaction on Tuesday, April 18th. The stock was bought at an average cost of GBX 1,647 ($21.16) per share, with a total value of £1,367.01 ($1,755.95). Over the last ninety days, insiders acquired 718 shares of company stock valued at $1,183,024.

About GlaxoSmithKline plc

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:GSK”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.